Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets
暂无分享,去创建一个
[1] A. Navarro,et al. Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer , 2022, International journal of molecular sciences.
[2] W. Cho,et al. Lymph node micrometastasis in non-small cell lung cancer. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[3] Yi-long Wu,et al. Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives , 2021, Cancer communications.
[4] Ruihua Xu,et al. Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020 , 2021, Cancer communications.
[5] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[6] Tingting Qin,et al. Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling , 2020, Cancer biology & medicine.
[7] Qiang Zhou,et al. Identification of three circular RNA cargoes in serum exosomes as diagnostic biomarkers of non-small-cell lung cancer in the Chinese population. , 2020, The Journal of molecular diagnostics : JMD.
[8] Wanqing Chen,et al. Cancer burden of major cancers in China: A need for sustainable actions , 2020, Cancer communications.
[9] Yan Zhang,et al. Serum exosomal miR‐378 upregulation is associated with poor prognosis in non–small‐cell lung cancer patients , 2020, Journal of clinical laboratory analysis.
[10] Yili Yang,et al. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer , 2020, Theranostics.
[11] Z. Deng,et al. Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN. , 2020, Life sciences.
[12] Zai-lin Yang,et al. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer , 2020, International journal of biological sciences.
[13] R. Fiorotto,et al. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. , 2019, Journal of hepatology.
[14] M. Majima,et al. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[15] X. Qiu,et al. CCL21/CCR7 up-regulate vascular endothelial growth factor-D expression via ERK pathway in human non-small cell lung cancer cells. , 2015, International journal of clinical and experimental pathology.
[16] Yan-wen Yao,et al. Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice. , 2015, Translational lung cancer research.
[17] Takashi Takahashi,et al. Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages , 2014, PloS one.
[18] S. Stacker,et al. Lymphangiogenesis and lymphatic vessel remodelling in cancer , 2014, Nature Reviews Cancer.
[19] H. Ji,et al. Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis , 2012, Proceedings of the National Academy of Sciences.
[20] Tara Karnezis,et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. , 2012, Cancer cell.
[21] K. Alitalo,et al. Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis , 2012, Journal of the National Cancer Institute.
[22] Xiao-li Zhang,et al. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. , 2011, European journal of cancer.
[23] K. Alitalo,et al. Lymphangiogenesis: Molecular Mechanisms and Future Promise , 2010, Cell.
[24] A. Hansen,et al. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. , 2006, Blood.
[25] A. Steiner,et al. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. , 2013, The Journal of investigative dermatology.